-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, TMiqLa5EuxJhDKuksWtJyfVGyLZytOC+C6b8kjxxSW6fYjeWqEsH+z8TgrrEEDYF b0mCMryD/Lp1DwmVY1KxfA== 0001140361-09-025141.txt : 20091106 0001140361-09-025141.hdr.sgml : 20091106 20091106204121 ACCESSION NUMBER: 0001140361-09-025141 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20091104 FILED AS OF DATE: 20091106 DATE AS OF CHANGE: 20091106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wei Eric CENTRAL INDEX KEY: 0001368570 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33650 FILM NUMBER: 091166300 MAIL ADDRESS: STREET 1: SUITE 602, CHINA LIFE TOWER STREET 2: 16 CHAOWAI DISTRICT CITY: BEIJING STATE: F4 ZIP: 100020 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NeoStem, Inc. CENTRAL INDEX KEY: 0000320017 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 222343568 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 420 LEXINGTON AVENUE STREET 2: SUITE 450 CITY: NEW YORK STATE: NY ZIP: 10170 BUSINESS PHONE: 212-584-4171 MAIL ADDRESS: STREET 1: 420 LEXINGTON AVENUE STREET 2: SUITE 450 CITY: NEW YORK STATE: NY ZIP: 10170 FORMER COMPANY: FORMER CONFORMED NAME: PHASE III MEDICAL INC/DE DATE OF NAME CHANGE: 20030819 FORMER COMPANY: FORMER CONFORMED NAME: CORNICHE GROUP INC /DE DATE OF NAME CHANGE: 19951117 FORMER COMPANY: FORMER CONFORMED NAME: FIDELITY MEDICAL INC DATE OF NAME CHANGE: 19951025 4 1 doc1.xml FORM 4 X0303 4 2009-11-04 0 0000320017 NeoStem, Inc. NBS 0001368570 Wei Eric C/O NEOSTEM, INC. 420 LEXINGTON AVENUE, SUITE 450 NEW YORK NY 10170 1 0 0 0 Stock Options (right to buy) 1.66 2009-11-04 4 A 0 150000 0 A 2019-11-03 Common Stock, par value $0.001 per share 150000 150000 D On November 4, 2009, the date of grant ("Grant Date"), the reporting person was granted an option to purchase 150,000 shares of common stock of NeoStem, Inc. (the "Company") pursuant and subject to the Company's 2009 Equity Compensation Plan. This option vests as to 50,000 shares on each of the first, second and third anniversaries of the Grant Date. Eric H. C. Wei, By: /s/ Catherine M. Vaczy, Esq., Attorney-in-Fact 2009-11-06 -----END PRIVACY-ENHANCED MESSAGE-----